| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/BMJ.2.6196.964 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1596588 |
| https://europepmc.org/articles/PMC1596588?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/bmj.2.6196.964 | ||
| P932 | PMC publication ID | 1596588 |
| P698 | PubMed publication ID | 509177 |
| P2093 | author name string | T. W. Meade | |
| Y. Stirling | |||
| R. Chakrabarti | |||
| H. Keen | |||
| R. J. Jarrett | |||
| J. H. Fuller | |||
| W. R. North | |||
| T. Omer | |||
| P2860 | cites work | THE BLOOD COAGULABILITY IN DIABETIC PATIENTS | Q76627720 |
| Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity | Q79470428 | ||
| Deterioration of the Microcirculation in Diabetes | Q36610482 | ||
| Diabetic retinopathy and the fibrinolytic system | Q39331529 | ||
| Platelet abnormalities in diabetic peripheral neuropathy | Q39363319 | ||
| Letter: Fibrinolytic activity in treatment of diabetes | Q39392549 | ||
| Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen | Q39459157 | ||
| Population-based distributions of haemostatic variables | Q39708097 | ||
| Platelet functions in diabetes mellitus | Q39720832 | ||
| Rationale for Antiplatelet Agents in Diabetic Vascular Disease | Q39770084 | ||
| Platelets and Thrombosis in the Development of Atherosclerosis and Its Complications | Q39770096 | ||
| Alteration of plasma antithrombin III levels in ischemic heart disease | Q64930778 | ||
| Determination of Platelet and Fibrinogen Half-Life with [75Se]Selenomethionine: Studies in Normal and in Diabetic Subjects | Q66956086 | ||
| Adenosinediphosphate induced platelet adhesiveness in diabetes mellitus with complications | Q70612933 | ||
| Platelet adhesiveness and aggregation in relation to diabetic retinopathy | Q70638703 | ||
| Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus | Q71524902 | ||
| Thrombocytes and coagulability in diabetics | Q72356060 | ||
| P433 | issue | 6196 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | engineering | Q11023 |
| P304 | page(s) | 964-966 | |
| P577 | publication date | 1979-10-01 | |
| 1979-10-20 | |||
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Haemostatic variables associated with diabetes and its complications | |
| P478 | volume | 2 |
| Q46020499 | A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus |
| Q43506884 | A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors |
| Q41847991 | A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control |
| Q33642432 | Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion |
| Q70710856 | Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathy |
| Q44962315 | Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular Complications |
| Q92140401 | Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients |
| Q36723030 | Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease |
| Q71789916 | Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria |
| Q64096487 | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
| Q51623641 | Blood glucose may condition factor VII levels in diabetic and normal subjects. |
| Q28192271 | Cardiovascular disease: much more aggressive in patients with type 2 diabetes |
| Q73315387 | Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus |
| Q70341192 | Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? |
| Q40784858 | Circulating acute phase reactive proteins as indicators of infection in poorly controlled diabetes mellitus |
| Q70289875 | Clinical trials of an antiplatelet agent, ticlopidine, in diabetes mellitus |
| Q71993564 | Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients |
| Q35314944 | Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients |
| Q33326452 | Contrasting Fibrinolytic Responses in Type 1 (Insulin-dependent) and Type 2 (Non-insulin-dependent) Diabetes |
| Q36682356 | Coronary heart disease in diabetes mellitus--antecedents and associations |
| Q72425481 | Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study |
| Q36254207 | Diabetes as a risk factor for acute coronary syndrome in women compared with men: a meta-analysis, including 10 856 279 individuals and 106 703 acute coronary syndrome events |
| Q83351946 | Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes |
| Q44663374 | Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London |
| Q37934887 | Dyslipoproteinemia and diabetes. |
| Q41143875 | Effect of high-fibre diet on haemostatic variables in diabetes |
| Q51451135 | Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus. |
| Q72127817 | Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus |
| Q33613657 | Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? |
| Q34251047 | Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. |
| Q72659901 | Factor VII in non-insulin-dependent diabetic patients with microalbuminuria |
| Q71452074 | Factor X and pancreatic islet A cell |
| Q33612628 | Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study |
| Q34488611 | Fibrinogen: a possible link between social class and coronary heart disease |
| Q73295903 | Genetic Modulation of Plasma Fibrinogen Concentrations: Possible Importance of Interleukin-6 |
| Q84895906 | Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy |
| Q71574538 | Haemostatic changes in diabetic coma |
| Q72423400 | Haemostatic function and cardiovascular death: early results of a prospective study |
| Q41675668 | Hemostatic concomitants of syndrome X |
| Q41047291 | Hemostatic factors as triggers of cardiovascular events. |
| Q51647241 | Hypertriglyceridaemia and hypercoagulability |
| Q46568984 | Immunohistochemical identification of factor X-like antigen in the A cells of the normal human pancreas |
| Q73384093 | Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease |
| Q35557363 | Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes |
| Q36778735 | Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities |
| Q40582663 | Lipoproteins and the haemostatic system in atherothrombotic disorders |
| Q35314442 | Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy? |
| Q47729722 | Methylglyoxal, glyoxalases and the development of diabetic complications |
| Q36761010 | Myocardial infarct size and mortality in diabetic patients |
| Q47775284 | Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline |
| Q81066721 | Pathogenesis of diabetic nephropathy |
| Q59796558 | Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels |
| Q50994520 | Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy. |
| Q35729514 | Plasma fibrinogen and factor VII as risk factors for cardiovascular disease |
| Q68211322 | Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics |
| Q37183198 | Platelet and coagulation factors in proliferative diabetic retinopathy |
| Q70890407 | Platelet life-span in diabetics with and without retinopathy |
| Q36493199 | Postprandial hyperglycaemia: to treat or not to treat? |
| Q50952344 | Progression of normal glucose tolerance to impaired glucose tolerance or diabetes in the elderly. |
| Q71550949 | Prolonged disease-free survival in diabetics |
| Q34117248 | Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction |
| Q35748423 | Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins |
| Q33610696 | Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study |
| Q35688919 | Retinopathy in juvenile diabetes: a 10-year (1990-2000) review |
| Q35168292 | Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. |
| Q42345954 | Specific heart disease in diabetes mellitus |
| Q38515709 | The 5-year prognosis for vision in diabetes. |
| Q45309131 | The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure |
| Q57066613 | The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation |
| Q34137134 | The association of angina pectoris with heart disease mortality among men and women by diabetes status: the Rancho Bernardo Study |
| Q41791338 | The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers |
| Q73798636 | The impact of coexistent diabetes on the prevalence of coronary heart disease |
| Q53761692 | The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy. |
| Q72616618 | Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients |
| Q73365825 | Thrombophilia in Patients with Hypertriglyceridemia |
| Q71434187 | Thrombophilia in patients with hypercholesterolemia |
| Q40174964 | Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither? |
| Q44976642 | Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria |
| Q71167257 | Venous thrombosis in diabetes mellitus |
| Q74840868 | Vitamin K-dependent and vitamin K-independent hypocoagulant effects of dietary fish oil in rats |
Search more.